Up 12% on news that the FDA will review the resubmission.
After being up 80% on news that the FDA will accept a resubmission and review it.
A resubmission for approval for the third time.
None of this is unexpected or surprising. And the verdict is still just as uncertain as it always has been.
I would be wary buying at these prices, as it seems to be very hype driven. It's absolutely not driven by fundamentals at this point.
IMO, DYOR.
Fingers crossed third time is the charm
Up 12% on news that the FDA will review the resubmission.After...
-
- There are more pages in this discussion • 206 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
0.010(1.03%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 99.5¢ | 96.5¢ | $1.393M | 1.424M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 12709 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.5¢ | 43746 | 15 |
View Market Depth
| Last trade - 12.49pm 26/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |